| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Adipose Tissue, Brown | 11 | 2024 | 124 | 5.190 |
Why?
|
| Proto-Oncogene Proteins c-akt | 17 | 2022 | 215 | 3.220 |
Why?
|
| Mechanistic Target of Rapamycin Complex 2 | 9 | 2020 | 17 | 2.900 |
Why?
|
| Adipocytes | 14 | 2022 | 273 | 2.720 |
Why?
|
| TOR Serine-Threonine Kinases | 19 | 2022 | 132 | 2.650 |
Why?
|
| Adipose Tissue, White | 10 | 2022 | 92 | 2.490 |
Why?
|
| Adipocytes, Brown | 8 | 2023 | 46 | 2.250 |
Why?
|
| Adipogenesis | 9 | 2019 | 81 | 2.120 |
Why?
|
| Lipogenesis | 7 | 2020 | 66 | 2.020 |
Why?
|
| Thermogenesis | 8 | 2024 | 127 | 2.010 |
Why?
|
| Obesity | 11 | 2023 | 1266 | 1.920 |
Why?
|
| ATP Citrate (pro-S)-Lyase | 3 | 2024 | 17 | 1.630 |
Why?
|
| Glutamine | 2 | 2024 | 50 | 1.600 |
Why?
|
| Protein Kinases | 10 | 2009 | 153 | 1.520 |
Why?
|
| Multiprotein Complexes | 10 | 2016 | 156 | 1.520 |
Why?
|
| Insulin | 9 | 2022 | 695 | 1.460 |
Why?
|
| Rapamycin-Insensitive Companion of mTOR Protein | 9 | 2022 | 12 | 1.420 |
Why?
|
| Signal Transduction | 26 | 2022 | 3143 | 1.240 |
Why?
|
| Transcription Factors | 10 | 2017 | 1551 | 1.180 |
Why?
|
| Diabetes Mellitus, Type 2 | 4 | 2022 | 731 | 1.170 |
Why?
|
| Animals | 48 | 2024 | 21292 | 1.100 |
Why?
|
| Carrier Proteins | 8 | 2020 | 718 | 1.090 |
Why?
|
| Adipose Tissue | 6 | 2024 | 299 | 1.070 |
Why?
|
| Subcutaneous Fat | 2 | 2020 | 50 | 1.060 |
Why?
|
| Glucose | 7 | 2023 | 476 | 1.030 |
Why?
|
| Mice | 32 | 2024 | 11088 | 1.030 |
Why?
|
| Myogenic Regulatory Factor 5 | 4 | 2014 | 16 | 1.010 |
Why?
|
| Neoplasms | 5 | 2023 | 1365 | 0.940 |
Why?
|
| Insulin Resistance | 7 | 2019 | 414 | 0.920 |
Why?
|
| Mechanistic Target of Rapamycin Complex 1 | 9 | 2017 | 54 | 0.890 |
Why?
|
| Nuclear Proteins | 5 | 2019 | 790 | 0.870 |
Why?
|
| Cell Lineage | 8 | 2019 | 282 | 0.860 |
Why?
|
| Basic Helix-Loop-Helix Leucine Zipper Transcription Factors | 4 | 2019 | 41 | 0.820 |
Why?
|
| PTEN Phosphohydrolase | 4 | 2012 | 88 | 0.820 |
Why?
|
| Adipocytes, White | 2 | 2015 | 27 | 0.810 |
Why?
|
| Metabolic Diseases | 1 | 2024 | 59 | 0.810 |
Why?
|
| Lipid Metabolism | 4 | 2020 | 225 | 0.800 |
Why?
|
| Phosphatidylinositol 3-Kinases | 5 | 2012 | 178 | 0.770 |
Why?
|
| Acetyl Coenzyme A | 1 | 2023 | 23 | 0.770 |
Why?
|
| ADP-Ribosylation Factor 1 | 1 | 2022 | 5 | 0.750 |
Why?
|
| Protein Interaction Maps | 1 | 2022 | 35 | 0.740 |
Why?
|
| Stress, Physiological | 1 | 2024 | 209 | 0.740 |
Why?
|
| Cold Temperature | 2 | 2021 | 50 | 0.700 |
Why?
|
| Isotope Labeling | 1 | 2021 | 69 | 0.690 |
Why?
|
| Energy Metabolism | 5 | 2022 | 396 | 0.640 |
Why?
|
| Forkhead Box Protein O1 | 2 | 2019 | 17 | 0.630 |
Why?
|
| Cell Growth Processes | 2 | 2012 | 36 | 0.630 |
Why?
|
| Fatty Acids | 4 | 2024 | 197 | 0.620 |
Why?
|
| Second Messenger Systems | 1 | 2019 | 27 | 0.620 |
Why?
|
| Cell Division | 5 | 2006 | 449 | 0.620 |
Why?
|
| Sirtuins | 1 | 2019 | 26 | 0.600 |
Why?
|
| Lipolysis | 1 | 2019 | 47 | 0.590 |
Why?
|
| Protein Kinase Inhibitors | 2 | 2012 | 197 | 0.590 |
Why?
|
| Muscle Development | 2 | 2019 | 57 | 0.580 |
Why?
|
| Sirtuin 1 | 1 | 2018 | 27 | 0.570 |
Why?
|
| Oncogenes | 1 | 2019 | 70 | 0.570 |
Why?
|
| Gastrointestinal Transit | 1 | 2018 | 6 | 0.560 |
Why?
|
| Phosphorylation | 10 | 2022 | 961 | 0.550 |
Why?
|
| Sirolimus | 6 | 2012 | 93 | 0.540 |
Why?
|
| Gene Knockout Techniques | 3 | 2020 | 96 | 0.530 |
Why?
|
| Trans-Activators | 2 | 2012 | 320 | 0.530 |
Why?
|
| Mice, Inbred C57BL | 10 | 2021 | 3469 | 0.510 |
Why?
|
| Humans | 35 | 2025 | 64958 | 0.510 |
Why?
|
| Lipodystrophy | 1 | 2017 | 11 | 0.510 |
Why?
|
| Cell Cycle Proteins | 4 | 2004 | 402 | 0.470 |
Why?
|
| Prostatic Neoplasms | 2 | 2012 | 493 | 0.460 |
Why?
|
| Protein Subunits | 1 | 2016 | 169 | 0.460 |
Why?
|
| Cell Differentiation | 5 | 2019 | 1385 | 0.460 |
Why?
|
| Homologous Recombination | 1 | 2015 | 28 | 0.450 |
Why?
|
| rab1 GTP-Binding Proteins | 1 | 2014 | 6 | 0.440 |
Why?
|
| Integrases | 1 | 2015 | 41 | 0.440 |
Why?
|
| Liver | 3 | 2016 | 868 | 0.420 |
Why?
|
| Homeodomain Proteins | 1 | 2015 | 277 | 0.390 |
Why?
|
| Citric Acid Cycle | 2 | 2024 | 29 | 0.390 |
Why?
|
| Schizosaccharomyces pombe Proteins | 3 | 2004 | 73 | 0.380 |
Why?
|
| Intracellular Signaling Peptides and Proteins | 2 | 2016 | 345 | 0.380 |
Why?
|
| Schizosaccharomyces | 4 | 2004 | 104 | 0.370 |
Why?
|
| Mice, Knockout | 7 | 2019 | 2152 | 0.350 |
Why?
|
| Colorectal Neoplasms | 1 | 2014 | 286 | 0.350 |
Why?
|
| Drosophila Proteins | 5 | 2011 | 758 | 0.340 |
Why?
|
| Cell Survival | 1 | 2012 | 587 | 0.330 |
Why?
|
| Protein Tyrosine Phosphatases | 2 | 2001 | 59 | 0.330 |
Why?
|
| Autophagy | 1 | 2012 | 231 | 0.320 |
Why?
|
| Fatty Acid Synthases | 2 | 2020 | 24 | 0.300 |
Why?
|
| Phosphotransferases (Alcohol Group Acceptor) | 1 | 2009 | 46 | 0.290 |
Why?
|
| Antibiotics, Antineoplastic | 2 | 2006 | 37 | 0.290 |
Why?
|
| Proteins | 9 | 2012 | 764 | 0.290 |
Why?
|
| Muscle, Skeletal | 4 | 2023 | 770 | 0.280 |
Why?
|
| Saccharomyces cerevisiae Proteins | 3 | 2004 | 449 | 0.280 |
Why?
|
| Protein Kinase C-alpha | 2 | 2006 | 17 | 0.270 |
Why?
|
| HEK293 Cells | 2 | 2020 | 615 | 0.260 |
Why?
|
| Forkhead Transcription Factors | 2 | 2011 | 132 | 0.260 |
Why?
|
| Ribosomal Protein S6 Kinases | 1 | 2006 | 10 | 0.250 |
Why?
|
| Genes, Developmental | 1 | 2006 | 5 | 0.250 |
Why?
|
| Drosophila | 3 | 2006 | 480 | 0.240 |
Why?
|
| Gene Expression Regulation | 4 | 2017 | 1629 | 0.230 |
Why?
|
| Male | 13 | 2023 | 30957 | 0.230 |
Why?
|
| Models, Biological | 5 | 2016 | 1192 | 0.220 |
Why?
|
| Metabolic Networks and Pathways | 2 | 2023 | 88 | 0.220 |
Why?
|
| Nucleotides | 1 | 2025 | 48 | 0.220 |
Why?
|
| Spindle Apparatus | 2 | 2002 | 125 | 0.220 |
Why?
|
| Aneuploidy | 1 | 2025 | 42 | 0.220 |
Why?
|
| Gene Expression | 2 | 2020 | 852 | 0.210 |
Why?
|
| PPAR gamma | 3 | 2020 | 77 | 0.210 |
Why?
|
| Glycolysis | 2 | 2021 | 59 | 0.210 |
Why?
|
| Mice, Transgenic | 2 | 2019 | 1287 | 0.200 |
Why?
|
| Mitosis | 2 | 2002 | 222 | 0.200 |
Why?
|
| Disease Models, Animal | 4 | 2023 | 2281 | 0.200 |
Why?
|
| Body Fat Distribution | 2 | 2013 | 13 | 0.190 |
Why?
|
| Genes, cdc | 1 | 2002 | 15 | 0.190 |
Why?
|
| Adipokines | 1 | 2022 | 36 | 0.190 |
Why?
|
| RNA Interference | 6 | 2011 | 643 | 0.180 |
Why?
|
| Protein Interaction Mapping | 1 | 2022 | 69 | 0.180 |
Why?
|
| Genomics | 2 | 2024 | 383 | 0.180 |
Why?
|
| DNA Damage | 1 | 2024 | 297 | 0.180 |
Why?
|
| Phosphatidylglycerols | 1 | 2021 | 12 | 0.180 |
Why?
|
| Metabolomics | 1 | 2022 | 62 | 0.170 |
Why?
|
| Cells, Cultured | 5 | 2014 | 2188 | 0.170 |
Why?
|
| Cell Transformation, Neoplastic | 3 | 2012 | 205 | 0.170 |
Why?
|
| Luminescent Proteins | 3 | 2012 | 129 | 0.170 |
Why?
|
| Metabolome | 1 | 2021 | 36 | 0.170 |
Why?
|
| Gene Targeting | 2 | 2015 | 77 | 0.170 |
Why?
|
| Protein Binding | 5 | 2009 | 1639 | 0.170 |
Why?
|
| Female | 10 | 2025 | 33929 | 0.160 |
Why?
|
| Diet, High-Fat | 3 | 2019 | 180 | 0.160 |
Why?
|
| Oxidation-Reduction | 1 | 2021 | 325 | 0.160 |
Why?
|
| Amino Acids | 1 | 2021 | 148 | 0.160 |
Why?
|
| Homeostasis | 3 | 2019 | 377 | 0.160 |
Why?
|
| Acetate-CoA Ligase | 1 | 2020 | 1 | 0.160 |
Why?
|
| Response Elements | 1 | 2020 | 44 | 0.160 |
Why?
|
| Glucose Transporter Type 4 | 1 | 2020 | 60 | 0.160 |
Why?
|
| Adult | 4 | 2023 | 17314 | 0.150 |
Why?
|
| Gene Expression Profiling | 4 | 2011 | 793 | 0.150 |
Why?
|
| Transcriptome | 2 | 2021 | 398 | 0.150 |
Why?
|
| Neural Crest | 1 | 2019 | 30 | 0.150 |
Why?
|
| HeLa Cells | 2 | 2019 | 541 | 0.150 |
Why?
|
| Protein Methyltransferases | 1 | 2019 | 13 | 0.150 |
Why?
|
| Proteome | 1 | 2020 | 151 | 0.150 |
Why?
|
| Dietary Carbohydrates | 1 | 2019 | 62 | 0.150 |
Why?
|
| Neural Stem Cells | 1 | 2019 | 47 | 0.150 |
Why?
|
| Histone-Lysine N-Methyltransferase | 1 | 2019 | 37 | 0.150 |
Why?
|
| Amino Acids, Branched-Chain | 1 | 2018 | 13 | 0.140 |
Why?
|
| Tumor Suppressor Proteins | 2 | 2012 | 210 | 0.140 |
Why?
|
| Methylation | 1 | 2019 | 130 | 0.140 |
Why?
|
| Neurogenesis | 1 | 2019 | 64 | 0.140 |
Why?
|
| Stromal Cells | 1 | 2018 | 78 | 0.130 |
Why?
|
| Proteomics | 1 | 2020 | 292 | 0.130 |
Why?
|
| Uncoupling Protein 1 | 1 | 2017 | 51 | 0.130 |
Why?
|
| Gene Deletion | 2 | 2016 | 311 | 0.130 |
Why?
|
| Carcinogenesis | 1 | 2019 | 134 | 0.130 |
Why?
|
| Adaptor Proteins, Signal Transducing | 4 | 2013 | 440 | 0.120 |
Why?
|
| Diabetes Mellitus, Experimental | 1 | 2017 | 206 | 0.120 |
Why?
|
| Histones | 1 | 2020 | 494 | 0.120 |
Why?
|
| Epigenesis, Genetic | 1 | 2020 | 406 | 0.120 |
Why?
|
| Receptors, Immunologic | 1 | 2017 | 179 | 0.120 |
Why?
|
| Flow Cytometry | 2 | 2012 | 662 | 0.120 |
Why?
|
| Protein Structure, Tertiary | 4 | 2015 | 676 | 0.120 |
Why?
|
| Tuberculosis | 1 | 2019 | 305 | 0.120 |
Why?
|
| Mutation | 4 | 2006 | 2657 | 0.120 |
Why?
|
| Gene Editing | 1 | 2020 | 327 | 0.110 |
Why?
|
| Organ Specificity | 1 | 2016 | 198 | 0.110 |
Why?
|
| Gene Expression Regulation, Developmental | 1 | 2019 | 662 | 0.110 |
Why?
|
| Inflammation | 2 | 2019 | 1186 | 0.110 |
Why?
|
| Cytoskeleton | 2 | 2006 | 140 | 0.110 |
Why?
|
| Up-Regulation | 2 | 2006 | 373 | 0.110 |
Why?
|
| Sterol Regulatory Element Binding Protein 1 | 2 | 2011 | 22 | 0.110 |
Why?
|
| Epithelial Cells | 2 | 2025 | 410 | 0.110 |
Why?
|
| Bone Morphogenetic Protein 7 | 1 | 2014 | 16 | 0.110 |
Why?
|
| MyoD Protein | 1 | 2014 | 45 | 0.110 |
Why?
|
| Receptor, Insulin | 1 | 2014 | 52 | 0.100 |
Why?
|
| Stem Cells | 1 | 2016 | 276 | 0.100 |
Why?
|
| Diet | 1 | 2017 | 533 | 0.100 |
Why?
|
| Cell Proliferation | 3 | 2013 | 1036 | 0.100 |
Why?
|
| Th2 Cells | 1 | 2013 | 93 | 0.100 |
Why?
|
| Proto-Oncogene Proteins | 2 | 2005 | 343 | 0.100 |
Why?
|
| Receptors, Cell Surface | 1 | 2015 | 431 | 0.100 |
Why?
|
| Receptors, Adrenergic, beta-3 | 1 | 2012 | 6 | 0.090 |
Why?
|
| Lipomatosis | 1 | 2012 | 7 | 0.090 |
Why?
|
| Histological Techniques | 1 | 2012 | 19 | 0.090 |
Why?
|
| Leukemia | 1 | 2012 | 62 | 0.090 |
Why?
|
| Hematopoiesis | 1 | 2012 | 127 | 0.090 |
Why?
|
| Muscle Cells | 1 | 2011 | 28 | 0.090 |
Why?
|
| Real-Time Polymerase Chain Reaction | 1 | 2012 | 211 | 0.090 |
Why?
|
| Sterol Regulatory Element Binding Protein 2 | 1 | 2011 | 6 | 0.090 |
Why?
|
| Sarcoma | 1 | 2011 | 36 | 0.090 |
Why?
|
| Cell Separation | 1 | 2011 | 147 | 0.090 |
Why?
|
| Reverse Transcriptase Polymerase Chain Reaction | 1 | 2012 | 542 | 0.090 |
Why?
|
| Ribosomal Protein S6 | 1 | 2011 | 1 | 0.080 |
Why?
|
| Lymphocyte Activation | 1 | 2013 | 752 | 0.080 |
Why?
|
| Drug Discovery | 1 | 2012 | 95 | 0.080 |
Why?
|
| Longevity | 1 | 2012 | 117 | 0.080 |
Why?
|
| Membrane Proteins | 1 | 2017 | 918 | 0.080 |
Why?
|
| Antineoplastic Agents | 2 | 2024 | 642 | 0.080 |
Why?
|
| Adenosine Triphosphate | 1 | 2012 | 299 | 0.080 |
Why?
|
| Regulatory-Associated Protein of mTOR | 4 | 2013 | 7 | 0.080 |
Why?
|
| Cell Line | 3 | 2015 | 2021 | 0.080 |
Why?
|
| Tacrolimus Binding Protein 1A | 1 | 2009 | 2 | 0.080 |
Why?
|
| Everolimus | 1 | 2009 | 22 | 0.070 |
Why?
|
| Microarray Analysis | 2 | 2011 | 64 | 0.070 |
Why?
|
| Green Fluorescent Proteins | 2 | 2001 | 372 | 0.070 |
Why?
|
| Mice, Obese | 2 | 2019 | 80 | 0.070 |
Why?
|
| T-Lymphocytes | 1 | 2013 | 1005 | 0.070 |
Why?
|
| Neoplasm Transplantation | 1 | 2009 | 168 | 0.070 |
Why?
|
| Fluorescent Antibody Technique | 3 | 2011 | 233 | 0.070 |
Why?
|
| Recombinant Proteins | 1 | 2011 | 710 | 0.070 |
Why?
|
| Mice, Nude | 1 | 2009 | 287 | 0.070 |
Why?
|
| Transplantation, Heterologous | 1 | 2009 | 240 | 0.070 |
Why?
|
| Prostate | 1 | 2009 | 122 | 0.070 |
Why?
|
| Phenotype | 2 | 2009 | 1231 | 0.070 |
Why?
|
| 3T3 Cells | 2 | 2018 | 111 | 0.070 |
Why?
|
| Aged, 80 and over | 1 | 2017 | 5601 | 0.070 |
Why?
|
| Young Adult | 1 | 2017 | 4795 | 0.070 |
Why?
|
| Mice, Inbred BALB C | 1 | 2009 | 869 | 0.060 |
Why?
|
| Forkhead Box Protein O3 | 1 | 2006 | 9 | 0.060 |
Why?
|
| Immunosuppressive Agents | 1 | 2009 | 380 | 0.060 |
Why?
|
| Fetal Viability | 1 | 2006 | 5 | 0.060 |
Why?
|
| Drosophila melanogaster | 3 | 2011 | 559 | 0.060 |
Why?
|
| Fetal Development | 1 | 2006 | 14 | 0.060 |
Why?
|
| Glycogen Synthase Kinase 3 beta | 1 | 2006 | 33 | 0.060 |
Why?
|
| Bacterial Proteins | 1 | 2012 | 739 | 0.060 |
Why?
|
| Fibroblasts | 1 | 2009 | 421 | 0.060 |
Why?
|
| Glycogen Synthase Kinase 3 | 1 | 2006 | 46 | 0.060 |
Why?
|
| Cell Enlargement | 1 | 2006 | 9 | 0.060 |
Why?
|
| Middle Aged | 3 | 2019 | 18210 | 0.060 |
Why?
|
| Embryo, Mammalian | 1 | 2006 | 158 | 0.060 |
Why?
|
| Precipitin Tests | 2 | 2004 | 77 | 0.060 |
Why?
|
| Genes, Tumor Suppressor | 1 | 2005 | 78 | 0.060 |
Why?
|
| Oxidative Phosphorylation | 1 | 2025 | 42 | 0.060 |
Why?
|
| Down-Regulation | 1 | 2006 | 324 | 0.060 |
Why?
|
| DNA Copy Number Variations | 1 | 2025 | 72 | 0.060 |
Why?
|
| Electrophoresis, Polyacrylamide Gel | 2 | 2004 | 185 | 0.060 |
Why?
|
| Mammary Glands, Human | 1 | 2025 | 56 | 0.060 |
Why?
|
| Blotting, Western | 2 | 2011 | 610 | 0.060 |
Why?
|
| Immunoblotting | 2 | 2004 | 202 | 0.050 |
Why?
|
| Cell Cycle | 3 | 2013 | 398 | 0.050 |
Why?
|
| Pyrimidines | 1 | 2025 | 145 | 0.050 |
Why?
|
| Transcription, Genetic | 2 | 2015 | 907 | 0.050 |
Why?
|
| Amino Acid Sequence | 3 | 2004 | 1589 | 0.050 |
Why?
|
| Molecular Sequence Data | 3 | 2004 | 1979 | 0.050 |
Why?
|
| Ribosomes | 1 | 2006 | 170 | 0.050 |
Why?
|
| Cell Line, Tumor | 2 | 2024 | 1564 | 0.050 |
Why?
|
| Adrenergic Agents | 1 | 2022 | 15 | 0.050 |
Why?
|
| Phosphoproteins | 1 | 2004 | 224 | 0.050 |
Why?
|
| Cell Death | 1 | 2024 | 289 | 0.050 |
Why?
|
| Plant Cells | 1 | 2002 | 11 | 0.050 |
Why?
|
| Actomyosin | 1 | 2002 | 21 | 0.050 |
Why?
|
| Yeasts | 1 | 2002 | 47 | 0.050 |
Why?
|
| Microtubule-Associated Proteins | 1 | 2002 | 115 | 0.050 |
Why?
|
| Carbon Isotopes | 1 | 2022 | 17 | 0.050 |
Why?
|
| Cyclin-Dependent Kinases | 1 | 2002 | 52 | 0.040 |
Why?
|
| Eukaryotic Cells | 1 | 2002 | 57 | 0.040 |
Why?
|
| Tumor Suppressor Protein p53 | 1 | 2024 | 318 | 0.040 |
Why?
|
| Microtubules | 1 | 2002 | 210 | 0.040 |
Why?
|
| Phosphotransferases | 1 | 2001 | 22 | 0.040 |
Why?
|
| Aged | 1 | 2017 | 14926 | 0.040 |
Why?
|
| RNA | 1 | 2004 | 426 | 0.040 |
Why?
|
| Catalysis | 1 | 2001 | 163 | 0.040 |
Why?
|
| Catalytic Domain | 1 | 2001 | 201 | 0.040 |
Why?
|
| Plasmids | 1 | 2001 | 294 | 0.040 |
Why?
|
| Structure-Activity Relationship | 1 | 2001 | 354 | 0.040 |
Why?
|
| Gene Ontology | 1 | 2020 | 37 | 0.040 |
Why?
|
| Mass Spectrometry | 1 | 2022 | 295 | 0.040 |
Why?
|
| Temperature | 1 | 2001 | 314 | 0.040 |
Why?
|
| Tubulin | 1 | 2000 | 73 | 0.040 |
Why?
|
| Chromatography, Liquid | 1 | 2020 | 117 | 0.040 |
Why?
|
| Alleles | 1 | 2001 | 453 | 0.040 |
Why?
|
| Mutagenesis | 1 | 2000 | 132 | 0.040 |
Why?
|
| Microscopy, Fluorescence | 1 | 2001 | 401 | 0.040 |
Why?
|
| Sequence Homology, Amino Acid | 1 | 2000 | 364 | 0.040 |
Why?
|
| Neural Tube | 1 | 2019 | 12 | 0.040 |
Why?
|
| Twist-Related Protein 1 | 1 | 2019 | 11 | 0.040 |
Why?
|
| Recombinant Fusion Proteins | 1 | 2001 | 500 | 0.040 |
Why?
|
| Cloning, Molecular | 1 | 2000 | 384 | 0.040 |
Why?
|
| Tandem Mass Spectrometry | 1 | 2020 | 137 | 0.040 |
Why?
|
| Acetylation | 1 | 2019 | 121 | 0.040 |
Why?
|
| Carnitine O-Acetyltransferase | 1 | 2018 | 1 | 0.040 |
Why?
|
| Mice, Mutant Strains | 1 | 2019 | 301 | 0.040 |
Why?
|
| Neuroglia | 1 | 2019 | 81 | 0.040 |
Why?
|
| Apoptosis | 1 | 2024 | 1100 | 0.040 |
Why?
|
| Protein Biosynthesis | 1 | 2001 | 331 | 0.040 |
Why?
|
| Lentivirus | 1 | 2018 | 64 | 0.030 |
Why?
|
| Single-Cell Analysis | 1 | 2019 | 115 | 0.030 |
Why?
|
| Cytosol | 1 | 2018 | 182 | 0.030 |
Why?
|
| Hypoxia | 1 | 2018 | 119 | 0.030 |
Why?
|
| DNA-Binding Proteins | 1 | 2004 | 1224 | 0.030 |
Why?
|
| Ubiquitin-Conjugating Enzymes | 1 | 2016 | 24 | 0.030 |
Why?
|
| 3T3-L1 Cells | 1 | 2017 | 90 | 0.030 |
Why?
|
| NIH 3T3 Cells | 1 | 2017 | 99 | 0.030 |
Why?
|
| Nerve Tissue Proteins | 1 | 2019 | 428 | 0.030 |
Why?
|
| Bone Morphogenetic Proteins | 1 | 2017 | 64 | 0.030 |
Why?
|
| RNA, Small Interfering | 2 | 2018 | 980 | 0.030 |
Why?
|
| Ubiquitination | 1 | 2016 | 117 | 0.030 |
Why?
|
| Mitochondria | 1 | 2020 | 401 | 0.030 |
Why?
|
| Gene Knockdown Techniques | 1 | 2017 | 203 | 0.030 |
Why?
|
| Neovascularization, Physiologic | 1 | 2017 | 113 | 0.030 |
Why?
|
| Breast Neoplasms | 1 | 2025 | 1217 | 0.030 |
Why?
|
| CCAAT-Enhancer-Binding Protein-alpha | 1 | 2015 | 14 | 0.030 |
Why?
|
| CCAAT-Enhancer-Binding Protein-beta | 1 | 2015 | 22 | 0.030 |
Why?
|
| RNA Polymerase II | 1 | 2015 | 86 | 0.030 |
Why?
|
| Mycobacterium tuberculosis | 1 | 2019 | 417 | 0.030 |
Why?
|
| CRISPR-Cas Systems | 1 | 2018 | 368 | 0.030 |
Why?
|
| Enzyme Activation | 2 | 2005 | 391 | 0.030 |
Why?
|
| Sequence Alignment | 2 | 2004 | 300 | 0.030 |
Why?
|
| Neurons | 1 | 2019 | 933 | 0.020 |
Why?
|
| Hematopoietic Stem Cell Mobilization | 1 | 2012 | 15 | 0.020 |
Why?
|
| Gene Expression Regulation, Leukemic | 1 | 2012 | 51 | 0.020 |
Why?
|
| Time Factors | 1 | 2000 | 3758 | 0.020 |
Why?
|
| Gluconeogenesis | 1 | 2012 | 15 | 0.020 |
Why?
|
| Glucose Clamp Technique | 1 | 2012 | 57 | 0.020 |
Why?
|
| Muscle Neoplasms | 1 | 2011 | 9 | 0.020 |
Why?
|
| Aurothioglucose | 1 | 2011 | 2 | 0.020 |
Why?
|
| Hepatocyte Nuclear Factor 3-beta | 1 | 2011 | 8 | 0.020 |
Why?
|
| Phosphatidate Phosphatase | 1 | 2011 | 1 | 0.020 |
Why?
|
| ras Proteins | 1 | 2011 | 76 | 0.020 |
Why?
|
| Survival Analysis | 1 | 2012 | 576 | 0.020 |
Why?
|
| Biomarkers | 1 | 2017 | 1476 | 0.020 |
Why?
|
| Muscle Fibers, Skeletal | 1 | 2011 | 96 | 0.020 |
Why?
|
| Hematopoietic Stem Cells | 1 | 2012 | 299 | 0.020 |
Why?
|
| Chromatin | 1 | 2015 | 641 | 0.020 |
Why?
|
| Molecular Targeted Therapy | 1 | 2011 | 128 | 0.020 |
Why?
|
| Triglycerides | 1 | 2011 | 248 | 0.020 |
Why?
|
| Immunohistochemistry | 1 | 2011 | 895 | 0.020 |
Why?
|
| Cytokines | 1 | 2013 | 951 | 0.020 |
Why?
|
| Gene Regulatory Networks | 1 | 2011 | 160 | 0.020 |
Why?
|
| Hematopoietic Stem Cell Transplantation | 1 | 2012 | 352 | 0.020 |
Why?
|
| Antirheumatic Agents | 1 | 2011 | 227 | 0.020 |
Why?
|
| Gene Expression Regulation, Neoplastic | 1 | 2011 | 583 | 0.020 |
Why?
|
| Genome | 1 | 2011 | 285 | 0.020 |
Why?
|
| Biomarkers, Tumor | 1 | 2011 | 521 | 0.020 |
Why?
|
| Rats | 1 | 2011 | 1989 | 0.020 |
Why?
|
| Models, Genetic | 1 | 2006 | 266 | 0.010 |
Why?
|
| 3-Phosphoinositide-Dependent Protein Kinases | 1 | 2005 | 5 | 0.010 |
Why?
|
| Immunoprecipitation | 1 | 2005 | 128 | 0.010 |
Why?
|
| Serine | 1 | 2005 | 90 | 0.010 |
Why?
|
| Gene Components | 1 | 2004 | 5 | 0.010 |
Why?
|
| Dose-Response Relationship, Drug | 1 | 2006 | 856 | 0.010 |
Why?
|
| Equipment Failure Analysis | 1 | 2004 | 78 | 0.010 |
Why?
|
| Conserved Sequence | 1 | 2004 | 173 | 0.010 |
Why?
|
| Protein Kinase C | 1 | 2004 | 102 | 0.010 |
Why?
|
| DNA Primers | 1 | 2004 | 301 | 0.010 |
Why?
|
| Macromolecular Substances | 1 | 2004 | 162 | 0.010 |
Why?
|
| Hydrophobic and Hydrophilic Interactions | 1 | 2005 | 281 | 0.010 |
Why?
|
| Genetic Testing | 1 | 2004 | 141 | 0.010 |
Why?
|
| Equipment Design | 1 | 2004 | 361 | 0.010 |
Why?
|
| Software | 1 | 2006 | 399 | 0.010 |
Why?
|
| Actins | 1 | 2004 | 263 | 0.010 |
Why?
|
| Sequence Analysis, DNA | 1 | 2004 | 414 | 0.010 |
Why?
|
| Transfection | 1 | 2004 | 701 | 0.010 |
Why?
|
| Image Processing, Computer-Assisted | 1 | 2006 | 698 | 0.010 |
Why?
|
| Reproducibility of Results | 1 | 2006 | 1692 | 0.010 |
Why?
|